Literature DB >> 29848191

Cystatin C and galectin-3 as therapeutic targets in heart failure.

Christos Zivlas1, Filippos Triposkiadis2, Stelios Psarras3, Gregory Giamouzis2, Ioannis Skoularigis2, Stavros Chryssanthopoulos3, Alkistis Kapelouzou3, Steve Ramcharitar4, Edward Barnes4, Evangelos Papasteriadis5, Dennis Cokkinos3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29848191      PMCID： PMC6041874          DOI： 10.1177/1753944718778470

Source DB:  PubMed          Journal:  Ther Adv Cardiovasc Dis        ISSN： 1753-9447


× No keyword cloud information.
  22 in total

1.  Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation.

Authors:  Lifang Xie; Jerome Terrand; Beibei Xu; George Tsaprailis; Jean Boyer; Qin M Chen
Journal:  Cardiovasc Res       Date:  2010-05-20       Impact factor: 10.787

2.  Letter to the Editor regarding the article 'Left atrial volume index in patients with heart failure and severely impaired left ventricular systolic function: the role of established echocardiographic parameters, circulating cystatin C and galectin-3' by Zivlas et al. (2017).

Authors:  Juan Pérez-Calvo; Jorge Rubio-Gracia; Claudia Josa-Laorden
Journal:  Ther Adv Cardiovasc Dis       Date:  2018-02-08

Review 3.  Galectin-3: a modifiable risk factor in heart failure.

Authors:  Rudolf A de Boer; A Rogier van der Velde; Christian Mueller; Dirk J van Veldhuisen; Stefan D Anker; W Frank Peacock; Kirkwood F Adams; Alan Maisel
Journal:  Cardiovasc Drugs Ther       Date:  2014-06       Impact factor: 3.727

4.  Association of Cardiac Galectin-3 Expression, Myocarditis, and Fibrosis in Chronic Chagas Disease Cardiomyopathy.

Authors:  Bruno Solano de Freitas Souza; Daniela Nascimento Silva; Rejane Hughes Carvalho; Gabriela Louise de Almeida Sampaio; Bruno Diaz Paredes; Luciana Aragão França; Carine Machado Azevedo; Juliana Fraga Vasconcelos; Cassio Santana Meira; Paulo Chenaud Neto; Simone Garcia Macambira; Kátia Nunes da Silva; Kyan James Allahdadi; Fabio Tavora; João David de Souza Neto; Ricardo Ribeiro Dos Santos; Milena Botelho Pereira Soares
Journal:  Am J Pathol       Date:  2017-03-17       Impact factor: 4.307

5.  Galectin-3 mediates the pulmonary arterial hypertension-induced right ventricular remodeling through interacting with NADPH oxidase 4.

Authors:  Jingni He; Xiaohui Li; Hui Luo; Tangzhiming Li; Lin Zhao; Qiangqiang Qi; Yuwei Liu; Zaixin Yu
Journal:  J Am Soc Hypertens       Date:  2017-03-27

6.  Association of cystatin C with heart failure with preserved ejection fraction in elderly hypertensive patients: potential role of altered collagen metabolism.

Authors:  Ana Huerta; Begoña López; Susana Ravassa; Gorka San José; Ramón Querejeta; Óscar Beloqui; Elena Zubillaga; Gregorio Rábago; Cristina Brugnolaro; Javier Díez; Arantxa González
Journal:  J Hypertens       Date:  2016-01       Impact factor: 4.844

7.  Estimating GFR using serum cystatin C alone and in combination with serum creatinine: a pooled analysis of 3,418 individuals with CKD.

Authors:  Lesley A Stevens; Josef Coresh; Christopher H Schmid; Harold I Feldman; Marc Froissart; John Kusek; Jerome Rossert; Frederick Van Lente; Robert D Bruce; Yaping Lucy Zhang; Tom Greene; Andrew S Levey
Journal:  Am J Kidney Dis       Date:  2008-03       Impact factor: 8.860

8.  Myocardial Galectin-3 Expression Is Associated with Remodeling of the Pressure-Overloaded Heart and May Delay the Hypertrophic Response without Affecting Survival, Dysfunction, and Cardiac Fibrosis.

Authors:  Olga Frunza; Ilaria Russo; Amit Saxena; Arti V Shinde; Claudio Humeres; Waqas Hanif; Vikrant Rai; Ya Su; Nikolaos G Frangogiannis
Journal:  Am J Pathol       Date:  2016-03-03       Impact factor: 4.307

9.  Cathepsin B inhibition attenuates cardiac dysfunction and remodeling following myocardial infarction by inhibiting the NLRP3 pathway.

Authors:  Aiguo Liu; Xuan Gao; Qingbin Zhang; Lianqun Cui
Journal:  Mol Med Rep       Date:  2013-06-04       Impact factor: 2.952

10.  Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway.

Authors:  Jun Feng; Hua-Wen Chen; Li-Juan Pi; Jin Wang; Da-Qian Zhan
Journal:  Oncotarget       Date:  2017-02-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.